You are here: Industry Insights > Luye Pharma

News List

Luye Pharma Releases Top-Line Results from a Phase II Clinical Trial of Its New Antidepressant Ansofaxine Hydrochloride Extended-Release Tablets prnasia
December 24, 2021
Luye Pharma Group today released the encouraging top-line results from a Phase II clinical trial of its new antidepressant, Ansofaxine Hydrochloride Extended-Release Tablets (LY03005)...
Luye Pharma Grants Zambon Exclusive Commercialization Rights to Its Innovative Alzheimer's Disease Treatment Rivastigmine Multi-Day Transdermal Patch in Switzerland prnasia
November 11, 2021
Luye Pharma Group (Luye Pharma) today announced that its subsidiary Luye Pharma Switzerland AG has entered into an agreement with Zambon Switzerland (Zambon)...
Luye Pharma Enters Distribution Agreement with Zuellig Pharma for Seroquel and Seroquel XR in Malaysia and Brunei, Strengthening Business Presence in Asia Pacific and Improving Access to Evidence-Base prnasia
August 02, 2021
Luye Pharma Group today announced that it has entered into an agreement with Zuellig Pharma, a leading healthcare service group in Asia, under which the company grants Zuellig Pharma exclusive rights to distribute its central nervous system drugs ...
Luye Pharma's Innovative Alzheimer's Disease Therapy Rivastigmine Multi-Day Transdermal Patch Now Eligible for Marketing Authorization in Several EU Countries prnasia
May 24, 2021
Luye Pharma Group today announced the successful completion of the Decentralised Registration Procedures (DCPs) for its Rivastigmine Multi-Day Transdermal Patch (Rivastigmine MD).
Luye Pharma and Distriphil Enter Exclusive Distribution Partnership in the Philippines with Joint Commitment to Raising Mental Health Awareness prnasia
November 27, 2020
Luye Pharma Group, an international pharmaceutical company dedicated to the R&D, manufacturing and sale of innovative medications has entered a new partnership agreement with Distribution Solutions Phils., Inc. (Distriphil), a national pharmaceutical ...
Luye Pharma Grants Cipla Medpro Exclusive Distribution and Marketing Rights for Seroquel® and Seroquel XR® in South Africa and Certain Neighbouring Countries prnasia
February 12, 2020
Luye Pharma Group has announced that it has entered into an exclusive distribution and marketing service agreement with Cipla Medpro South Africa (Pty) Limited (Cipla Medpro), for Seroquel® and Seroquel XR® in South Africa, Namibia and Botswana.
Luye Pharma's anti-depression drug to start clinical trials in Japan biospectrumasia
August 25, 2019
Submits a clinical trial application for Ansofaxine Hydrochloride Extended-Release Tablets (LY03005) for the treatment of depression
LY09004 Approved for Clinical Trials in China, Luye Pharma Steps-up Global R&D Investment in Biopharma Medicines firstwordpharma
April 04, 2019
Luye Pharma announced that the company has received approval from the National Medical Products Administration of China ……
AstraZeneca licences Luye Pharma cholesterol drug in China pharmaceutical-technology
January 21, 2019
Luye Pharma has granted AstraZeneca’s Chinese division exclusive rights to promote its cholesterol medicine Xuezhikang Capsules in mainland China.
Luye Pharma strengthens commitment to cardiovascular therapeutic field biospectrumasia
January 17, 2019
Luye Pharma grants AstraZeneca exclusives rights to promote Xuezhikang Capsules in mainland China.